Novozymes Buys Merck Crop Business for $275 Million
This article is for subscribers only.
Novozymes A/S, the world’s largest maker of industrial enzymes, agreed to buy Merck KGaA’s bioagriculture science unit for $275 million, adding a range of products designed to improve yields.
EMD/Merck Crop BioScience, which makes natural inoculants to improve plant health, has had an average annual growth of about 15 percent over the last seven years, with expected sales this year of $60 million, Novozymes said in a statement today.